Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Friday, August 19, 2022
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans
admin
-
August 17, 2022
Latest Pharma-News
Sanofi provides update on amcenestrant clinical development program
admin
-
August 17, 2022
Latest Pharma-News
Novartis provides update on Phase III CANOPY for NSCLC
admin
-
August 16, 2022
Latest Pharma-News
Monkeypox: experts give virus variants new names
admin
-
August 16, 2022
Latest Pharma-News
FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
admin
-
August 16, 2022
Latest Pharma-News
Health ministry issues notification to regulate all the medical devices under D&C Act from April 1, 2020
admin
-
February 17, 2020
0
Latest Pharma-News
New Phase IIIb Interim Data from the STARDUST Study Shows about Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission...
admin
-
February 17, 2020
0
Latest Pharma-News
Deciphera Pharmaceuticals Announces U.S. FDA Acceptance of NDA and Priority Review for Ripretinib in the Patients with Advanced Gastrointestinal Stromal Tumors
admin
-
February 17, 2020
0
Latest Pharma-News
U.S.FDA Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application for the Lisocabtagene Maraleucel (liso-cel) for the Adult Patients with Relapsed or Refractory Large...
admin
-
February 14, 2020
0
Latest Pharma-News
Merck’s Checkpoint Inhibitor Keytruda (pembrolizumab) Hits Another Mark in Breast Cancer
admin
-
February 14, 2020
0
Latest Pharma-News
Eli Lilly Announces Topline Results for the Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
admin
-
February 14, 2020
0
Latest Pharma-News
Novartis announces MET inhibitor capmatinib, the first potential treatment for the METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
admin
-
February 13, 2020
1
Latest Pharma-News
Bayer and Nuvisan generate new research unit in Berlin
admin
-
February 13, 2020
0
Latest Pharma-News
U.S. FDA granted fast track designation for Nanobiotix for the investigation of first-in-class nbtxr3 in head and neck cancer
admin
-
February 13, 2020
0
Latest Pharma-News
Astex Pharmaceuticals announces U.S. Food and Drug Administration (FDA) acceptance for the review of NDA for the combination oral hypomethylating agent cedazuridine and decitabine...
admin
-
February 13, 2020
0
Latest Pharma-News
U.S. FDA Acceptance of New Drug Application for FibroGen’s Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
admin
-
February 12, 2020
0
Latest Pharma-News
Fennec Pharmaceuticals Completes Rolling Submission of NDA to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to the...
admin
-
February 12, 2020
0
1
...
116
117
118
...
133
Page 117 of 133
- Advertisment -
Most Read
FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans
August 17, 2022
Sanofi provides update on amcenestrant clinical development program
August 17, 2022
Novartis provides update on Phase III CANOPY for NSCLC
August 16, 2022
Monkeypox: experts give virus variants new names
August 16, 2022